Videos
Advertisement
Pooja Desai discussed a study examining short- vs long-term results of SZC therapy on hyperkalemia-related hospitalization.
Dr. David Charytan shared his thoughts on his career and winning the NKF's J. Michael Lazarus Distinguished Award.
Dr. Sethi continues his comments on NER deficiency in gastric cancer cell lines in response to cisplatin treatment.
A group of kidney care experts proposed a new transplant-inclusive value-based care model to better incentivize transplant.
Dr. Marisa Bittoni discusses the possible link between vaping and lung cancer risk.
Drs. Nataliya Uboha and Christopher Lieu highlight a recent analysis of the KRYSTAL-1 trial for metastatic colorectal cancer.
Alister Campbell, of Dotmatics, details how artificial intelligence is changing the drug discovery process.
Dr. Townsend details the science behind aldosterone, the hormone that regulates sodium and helps regulate blood pressure.
Dr. Townsend discusses hypertension and how not adhering to medications is the biggest issue for patients.
Dr. Timothy Yap discusses the PETRA trial, which showed the efficacy of saruparib in treating HER2-negative breast cancer.
Drs. White and Berman consider how the post hoc analysis of CROSSFIRE elucidates the benefit of ablative therapy with IO.
Drs. White and Berman share insights gained from the CROSSFIRE trial comparing IRE with SBRT in advanced pancreatic cancer.
Dr. William Jarnagin discusses his recent study on characterizing the heterogeneity of intrahepatic cholangiocarcinoma.
Dr. Samilia Obeng-Gyasi discusses how social factors can impact outcomes in breast cancer patients.
Stacy Stephens explains how autonomous security robots are boosting surveillance and communication in hospitals.
Arun Krishna, of AstraZeneca, talks about the phase 3 FLAURA2 trial, which assessed Tagrisso in patients with NSCLC.
Dr. Pant discusses the relationship between T cell response magnitude and tumor biomarker reduction.
Michael Spigler presents highlights of the American Kidney Fund's fifth annual Kidney Action Week.
Dr. Griffin shares data from their real-world study on pegcetacoplan in patients with paroxysmal nocturnal hemoglobinuria.
Dr. Grunwald of the Atrium Health Levine Cancer Institute, discusses caring for patients with PV on rare disease day.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.